Idofnib-150 Capsule is used to manage idiopathic pulmonary fibrosis, a chronic lung disease that causes scarring of the lung tissue. It belongs to a class of medications known as tyrosine kinase inhibitors, which work to slow down the progression of fibrotic lung disorders.
In addition to its main use, this medicine also helps manage other lung conditions characterised by progressive scarring. These include chronic fibrosing interstitial lung diseases with a progressive phenotype and systemic sclerosis-associated interstitial lung disease, an autoimmune condition that leads to hardening and scarring of lung tissue.
The recommended dosage is usually one capsule twice daily, but your doctor will determine the appropriate dose based on your specific condition. Before starting this medicine, inform your doctor about any pre-existing health issues or medications you are currently taking. Should you experience any side effects while using this medicine, notify your doctor promptly. Continue taking the medicine for the full duration prescribed by your doctor to achieve optimal results.